Kay Dickersin

Professor Emeritus

1980 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1980 2019

Filter
Review article
2019

Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews

Saldanha, I. J., Lindsley, K. B., Lum, F., Dickersin, K. & Li, T., Jan 1 2019, In : JAMA ophthalmology.

Research output: Contribution to journalReview article

Corneal Diseases
Practice Guidelines
Meta-Analysis
Therapeutics
Dry Eye Syndromes
2018

Caveat emptor: The combined effects of multiplicity and selective reporting 11 Medical and Health Sciences 1117 Public Health and Health Services

Li, T., Mayo-Wilson, E. R., Fusco, N., Hong, H. & Dickersin, K., Sep 17 2018, In : Trials. 19, 1, 497.

Research output: Contribution to journalReview article

Health Services
Public Health
Clinical Trials
Health
Information Storage and Retrieval
2017

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials

CONSORT Group, 2017, In : Japanese Pharmacology and Therapeutics. 45, 3, p. 479-487 9 p.

Research output: Contribution to journalReview article

Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis

Mayo-Wilson, E. R., Fusco, N., Li, T., Dickersin, K., Hong, H. & Canner, J. K., Jun 1 2017, In : Journal of Clinical Epidemiology. 86, p. 39-50 12 p.

Research output: Contribution to journalReview article

Randomized Controlled Trials
Clinical Trials
Research
Neuralgia
Bipolar Disorder

Non-surgical interventions for acute internal hordeolum

Lindsley, K., Nichols, J. J. & Dickersin, K., Jan 9 2017, In : Cochrane Database of Systematic Reviews. 2017, 1, CD007742.

Research output: Contribution to journalReview article

Hordeolum
MEDLINE
Chalazion
Eyelids
Patient Selection

SPIRIT 2013 statement: Defining standard protocol items for clinical trials

Chan, A. W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., Doré, C. J., Parulekar, W. R., Summerskill, W. S. M., Groves, T., Schulz, K. F., Sox, H. C., Rockhold, F. W., Rennie, M. & Moher, D., Jan 1 2017, In : Japanese Pharmacology and Therapeutics. 45, 12, p. 1895-1904 10 p.

Research output: Contribution to journalReview article

Clinical Trials
2015

Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: Elaboration and explanation

the PRISMA-P Group, Jan 2 2015, In : BMJ (Online). 349, g7647.

Research output: Contribution to journalReview article

Meta-Analysis
Documentation
Guidelines
Checklist
Publications
2014

Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

Moja, L., Lucenteforte, E., Kwag, K. H., Bertele, V., Campomori, A., Chakravarthy, U., D'Amico, R., Dickersin, K., Kodjikian, L., Lindsley, K., Loke, Y., Maguire, M., Martin, D. F., Mugelli, A., Mühlbauer, B., Püntmann, I., Reeves, B., Rogers, C., Schmucker, C., Subramanian, M. L. & 1 others, Virgili, G., Jul 24 2014, In : Cochrane Database of Systematic Reviews. 2014, 7, CD011230.

Research output: Contribution to journalReview article

Macular Degeneration
Safety
Ranibizumab
Bevacizumab